Gadolinium-Enhanced Cardiovascular Magnetic Resonance: Administered Dose in Relationship to United States Food and Drug Administration (FDA) Guidelines
Journal of Cardiovascular Magnetic Resonance - United Kingdom
doi 10.1186/1532-429x-14-18
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2012
Authors
Publisher
Springer Science and Business Media LLC